221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Clinical trial NCT02484547 · TERMINATED

Trial details

NCT number: NCT02484547
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2015-09-15
Primary completion: 2019-08-05
Enrollment: 1643

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.